Advagraf medicine has the main active ingredient Tacrolimus and other excipients in sufficient quantities. Advagraf belongs to the group of anti-cancer drugs and affects the immune system. The drug is indicated for people after liver transplant, kidney transplant to prevent transplant rejection.